Related Experiment Video
Updated: Apr 7, 2026

Ex vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface
Published on: December 30, 2025
Hepatitis C Virus (HCV) Vertical Transmission in 12-Month-Old Infants Born to HCV-Infected Women and Assessment of
Ravi Jhaveri1, Mohamed Hashem2, Samer S El-Kamary2
1Division of Infectious Diseases, Department of Pediatrics , University of North Carolina at Chapel Hill School of Medicine.
Insights
Hepatitis C virus (HCV) vertical transmission (VT) in infants occurred at a 14.3% rate in Egypt. Maternal risk factors did not predict transmission, highlighting the need for better identification strategies and earlier infant testing.
Area of Science:
- Hepatology
- Virology
- Pediatric Infectious Diseases
Background:
- Hepatitis C virus (HCV) is a significant cause of pediatric liver disease, primarily transmitted from mother to child (vertical transmission).
- Current infant screening guidelines for HCV are based on older testing methods, necessitating updated data with real-time PCR (polymerase chain reaction).
- Previous studies reported HCV vertical transmission (VT) rates between 4%-15%, often linked to high maternal viral load.
Purpose of the Study:
- To evaluate HCV RNA in infants born to viremic mothers in Egypt.
- To assess maternal risk factors, including viral load, delivery mode, and IL28B genotype, associated with HCV vertical transmission (VT).
- To determine the 12-month HCV VT rate in a prospective cohort in Cairo, Egypt.
Main Methods:
- Prospective screening of pregnant women for HCV from December 2012 to March 2014.
- Testing of infants at 12 months of age for HCV RNA using real-time PCR if the mother was viremic.
- Analysis of maternal HCV RNA levels, mode of delivery, and IL28B genotype as potential risk factors for VT.
Main Results:
- A total of 54 out of 2514 pregnant women (2.1%) were viremic for HCV.
- Of 51 infants tested at 12 months, 7 were viremic, resulting in an HCV vertical transmission (VT) rate of 14.3% (7 of 49).
- No significant association was found between maternal risk factors (viral load, delivery mode, IL28B genotype) and HCV transmission to infants.
Conclusions:
- The study identified a 12-month HCV vertical transmission (VT) rate of 14.3% in Egypt, a region with high HCV endemicity.
- Maternal risk factors did not reliably predict HCV transmission, indicating a need for improved predictive methods.
- Further research should focus on identifying pregnant women at higher risk for VT and implementing earlier infant testing to detect potential chronicity.
Abstract:
Background. Hepatitis C virus (HCV) is an underappreciated cause of pediatric liver disease, most frequently acquired by vertical transmission (VT). Current guidelines that include the option of screening infants for HCV RNA at 1-2 months are based on data prior to current real-time polymerase chain reaction (PCR)-based testing. Previous studies have demonstrated VT rates of 4%-15% and an association with high maternal viral load. We evaluated HCV RNA in infants with HCV VT and assessed maternal risk factors in a prospective cohort in Cairo, Egypt. Methods. Pregnant women were screened for HCV from December 2012 to March 2014. For those with HCV viremia, their infants were tested at 12 months for HCV RNA using real-time PCR. Maternal risk factors assessed for HCV VT association included HCV RNA levels, mode of delivery, and maternal IL28B genotype. Results. Of 2514 women screened, a total of 54 women were viremic (2.1%) and delivered 56 infants. Of those, 51 infants of 49 women were tested at 12 months of age. Only 7 infants were viremic, with an HCV VT rate of 14.3% (7 of 49). Median HCV RNA in the infants was 2100 IU/mL. None of the maternal risk factors analyzed were associated with transmission. Conclusions. In Egypt where HCV is highly endemic, we observed an overall 12-month HCV VT rate of 14.3%. Further studies should focus on better identification of pregnant women more likely to vertically transmit HCV and earlier testing of infants to identify those likely to develop chronicity.
More Related Videos
05:53Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Cytomegalovirus Disease
Hepatitis
Development of the Oral Microbiota